CHRS

CHRS Total Liabilities

$130.35MQuarterly · USD

Period ending:

CHRS FY Total LiabilitiesUSD
CHRS FY Total Liabilities2012-12-31: $17.34M2013-12-31: $89.83M2014-12-31: $120.46M2015-12-31: $219.31M2016-12-31: $159.13M2017-12-31: $132.08M2018-12-31: $138.06M2019-12-31: $303.71M2020-12-31: $560.68M2021-12-31: $581.61M2022-12-31: $618.27M2023-12-31: $823.03M2024-12-31: $580.52M2025-12-31: $197.33M$823.03M$0.00
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CHRS total liabilities history

Total amount the company owes to creditors. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Coherus Oncology Inc Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)
197,329,000
580,523,000
823,029,000
618,265,000
581,608,000
560,675,000
303,713,000
138,058,000
132,076,000
159,131,000
219,313,000
120,464,000
89,829,000
17,341,000

Compare total liabilities

All CHRS financial metrics · CHRS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.